Trial intelligence / Profile preview

CHANCE-HF: CA125-guided therapy in heart failure

NCT02008110Phase 4Completed

Sponsor
INCLIVA Biomedical Research Institute
Start
Dec 2011
Primary completion
Jul 2014
Countries
1
01

Overview

Phase 4, randomised, open-label trial in heart failure (HF), sponsored by INCLIVA Biomedical Research Institute. Started Dec 2011; status: completed.

02

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT02008110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02008110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call